Epigenetics and Animal Health

Comprehensive Biotechnology, Second Edition

Volumn 4, Issue , 2011, Pages 381-394

  Karrow, N A ^a   Sharma, B S ^a   Fisher, R E ^a   Mallard, B A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Disease; Epigenetics; Epigenomics; Neuroendocrine immune system; Treatment and prevention

Indexed keywords

EID: 85012848179     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00289-0     Document Type: Chapter

References (46)

1. Ambros V., Lee R.C., Lavanway A., et al. MicroRNAs and other tiny endogenous RNAs in C. elegans. Current Biology 2003, 13:807-818.
2. Ambros V., Bartel B., Bartel D.P., et al. A uniform system for microRNA annotation. RNA 2003, 3:277-279.
3. Ammerpohl O., Martin-Subero J.I., Richter J., et al. Hunting for the 5th base: Techniques for analyzing DNA-methylation. BBA - General Subjects 2009, 1790:847-862.
4. Barad O., Meiri E., Avniel A., et al. MicroRNA expression detected by oligonucleotide microarrays: System establishment and expression profiling in human tissues. Genome Research 2004, 14:2486-2494.
5. Bormann Chung C.A., Boyd V.L., McKernan K.J., et al. Whole methylome analysis by ultra-deep sequencing using two-base encoding. PLoS One 2010, 5:e9320.
6. Castoldi M., Schmidt S., Benes V., et al. miChip: An array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nature Protocols 2008, 3:321-329.
7. Costello J.F., Fruhwald M.C., Smiraglia D.J., et al. Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns. Nature Genetics 2000, 24:132-138.
8. Dupont J.M., Tost J., Jammes H., Gut I.G. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Analytical Biochemistry 2004, 333:119-127.
9. Estecio M.R., Yan P.S., Ibrahim A.E., et al. High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Research 2007, 17:1529-1536.
10. Friedländer M.R., Chen W., Adamidi C., et al. Discovering microRNAs from deep sequencing data using miRDeep. Nature Biotechnology 2008, 26:407-415.
11. Frommer M., McDonald L.E., Millar D.S., et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:1827-1831.
12. Fukasawa M., Kimura M., Morita S., et al. Microarray analysis of promoter methylation in lung cancers. Journal of Human Genetics 2006, 51:368-374.
13. Garzon R., Pichiorri F., Palumbo T., et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007, 26:4148-4157.
14. Gebhard C., Schwarzfischer L., Pham T.H., et al. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Research 2006, 66:6118-6128.
15. Hackenberg M., Sturm M., Langenberger D., et al. miRanalyzer: A microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Research 2009, 37:W68-W76.
16. Hu M., Yao J., Polyak K. Methylation-specific digital karyotyping. Nature Protocols 2006, 1:1621-1636.
17. Huang T.H., Perry M.R., Laux D.E. Methylation profiling of CpG islands in human breast cancer cells. Human Molecular Genetics 1999, 8:459-470.
18. Ibrahim A.E., Thorne N.P., Baird K., et al. MMASS: An optimized array-based method for assessing CpG island methylation. Nucleic Acids Research 2006, 34:e136.
19. Jacinto F.V., Ballestar E., Esteller M. Methyl-DNA immunoprecipitation (MeDIP): Hunting down the DNA methylome. Biotechniques 2008, 44:35. 37, 39 passim.
20. Liang G., Gonzalgo M.L., Salem C., Jones P.A. Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction. Methods 2002, 27:150-155.
21. Mathelier A., Carbone A. MIReNA: Finding microRNAs with high accuracy and no learning at genome scale and from deep sequencing data. Bioinformatics 2010, 26:2226-2234.
22. Melnikov A.A., Gartenhaus R.B., Levenson A.S., et al. MSRE-PCR for analysis of gene-specific DNA methylation. Nucleic Acids Research 2005, 33:e93.
23. Mineno J., Okamoto S., Ando T., et al. The expression profile of microRNAs in mouse embryos. Nucleic Acids Research 2006, 34:1765-1771.
24. Nouzova M., Holtan N., Oshiro M.M., et al. Epigenomic changes during leukemia cell differentiation: Analysis of histone acetylation and cytosine methylation using CpG island microarrays. Journal of Pharmacology and Experimental Therapeutics 2004, 311:968-981.
25. O'Neill L.P., Turner B.M. Immunoprecipitation of native chromatin: NChIP. Methods 2003, 31:76-82.
26. Ordway J.M., Budiman M.A., Korshunova Y., et al. Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One 2007, 2:e1314.
27. Ordway J.M., Bedell J.A., Citek R.W., et al. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis 2006, 27:2409-2423.
28. Orlando V. Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends in Biochemical Sciences 2000, 25:99-104.
29. Park P.J. ChIP-seq: Advantages and challenges of a maturing technology. Nature Reviews Genetics 2009, 10:669-680.
30. Plass C., Shibata H., Kalcheva I., et al. Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nature Genetics 1996, 14:106-109.
31. Pomraning K.R., Smith K.M., Freitag M. Genome-wide high throughput analysis of DNA methylation in eukaryotes. Methods 2009, 47:142-150.
32. Rauch T.A., Pfeifer G.P. The MIRA method for DNA methylation analysis. Methods in Molecular Biology 2009, 507:65-75.
33. Reilly J.G., Thomas C.A., Sen A. DNA methylation in mouse cells in culture as measured by restriction enzymes. Biochimica et Biophysica Acta 1982, 697:53-59.
34. Rush L.J., Plass C. Restriction landmark genomic scanning for DNA methylation in cancer: Past, present, and future applications. Analytical Biochemistry 2002, 307:191-201.
35. Schilling E., Rehli M. Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 2007, 90:314-323.
36. Schmitz A., Short M., Ammerpohl O., et al. Cis-elements required for the demethylation of the mouse M-lysozyme downstream enhancer. Journal of Biological Chemistry 1997, 272:20850-20856.
37. Song F., Smith J.F., Kimura M.T., et al. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:3336-3341.
38. Takamizawa J., Konishi H., Yanagisawa K., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Research 2004, 64:3753-3756.
39. Taylor K.H., Kramer R.S., Davis J.W., et al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Research 2007, 67:8511-8518.
40. Toyota M., Ho C., Ahuja N., et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Research 1999, 59:2307-2312.
41. Válóczi A., Hornyik C., Varga N., et al. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Research 2004, 32:e175.
42. Wang T.L., Maierhofer C., Speicher M.R., et al. Digital karyotyping. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16156-16161.
43. Wei C.L., Wu Q., Vega V.B., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006, 124:207-219.
44. Weisenberger D.J., Trinh B.N., Campan M., et al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Research 2008, 36:4689-4698.
45. Yegnasubramanian S., Lin X., Haffner M.C., et al. Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation. Nucleic Acids Research 2006, 34:e19.
46. Zeng Y., Wagner E.J., Cullen B.R. Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Molecular Cell 2002, 9:1327-1333.